The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 Apr 2017 07:00

RNS Number : 4499B
Oxford Biomedica PLC
04 April 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford BioMedica plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Joy Group Limited

City and country of registered office (if applicable)

Road Town, Tortola, BVI

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

Trade date 03/04/2017 / Value date 05/04/2017

6. Date on which issuer notified (DD/MM/YYYY):

04/04/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.9%

Position of previous notification (if

applicable)

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0006648157

215,793,548

6.9%

SUBTOTAL 8. A

215,793,548

6.9%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Joy Group Limited

6.9%

Proxy voting

10. Name of the proxy holder

See section 3

11. The number and % of voting rights held

12. The date until which the voting rights will be held

13. Additional informationxvi

Joy Group Limited is a controlled undertaking of The Al Joy 1 Trust, which is a trust registered in Jersey

 

14. Contact name:

Tim Watts

15. Contact telephone number:

01865 783000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOARRBRASRUR
Date   Source Headline
28th Apr 20222:24 pmRNSDirector/PDMR Shareholding
27th Apr 20222:58 pmRNS2021 Annual report and accounts & AGM notification
27th Apr 202212:10 pmRNSPDMR Dealings / Market Share Purchase
21st Apr 20224:41 pmRNSDirector Share Purchase
21st Apr 20221:24 pmRNSDirectors Dealings / Market Share Purchase
21st Apr 202210:16 amRNSDirector/PDMR Shareholding
20th Apr 20223:45 pmRNSDirector/PDMR Shareholding
20th Apr 20227:00 amRNSPreliminary Results
13th Apr 20227:00 amRNSBoard Appointment
4th Apr 202211:34 amRNSNotice of Preliminary Results
1st Apr 20226:30 pmRNSHolding(s) in Company
1st Apr 202210:33 amRNSBlock listing Application
1st Apr 20229:34 amRNSTotal Voting Rights
31st Mar 20226:07 pmRNSHolding(s) in Company
30th Mar 20221:00 pmRNSHolding(s) in Company
25th Mar 20225:15 pmRNSHolding(s) in Company
21st Mar 202210:44 amRNSLong Term Incentive Plan Option Grant
15th Mar 202211:25 amRNSHolding(s) in Company
15th Mar 20229:39 amRNSHolding(s) in Company
11th Mar 20224:51 pmRNSHolding(s) in Company
11th Mar 20229:01 amRNSAdmission of Conditional Placing Shares
10th Mar 20225:32 pmRNSCompletion of Transaction
9th Mar 202211:42 amRNSDirector Declaration
8th Mar 20223:54 pmRNSResult of General Meeting
1st Mar 20229:52 amRNSTotal Voting Rights
16th Feb 202211:41 amRNSPublication of Circular & Notice of GM
4th Feb 20228:22 amRNSAdmission of Firm Placing Shares
1st Feb 20229:06 amRNSTotal Voting Rights
1st Feb 20227:00 amRNSUpdate to agreement with Sio Gene Therapies
31st Jan 202211:21 amRNSMarket Share Purchase
28th Jan 20225:59 pmRNSResult of Placing and PrimaryBid offer
28th Jan 20222:04 pmRNSHoldings in Company
28th Jan 20227:38 amRNSRetail offer by PrimaryBid
28th Jan 20227:24 amRNSUS Agreement and Proposed Placing of Shares
17th Jan 20227:00 amRNSJohn Dawson to retire from Oxford Biomedica
5th Jan 20227:00 amRNSOxford Biomedica Agreement with Cabaletta Bio
4th Jan 202211:07 amRNSBlock listing Return
4th Jan 202210:32 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSJohn Dawson awarded CBE in New Year Honours List
14th Dec 20217:00 amRNSBoard Appointment
13th Dec 20217:00 amRNSOxford Biomedica Updates Lentiviral Agreement
13th Dec 20217:00 amRNSOxford Biomedica Signs Agreement with Arcellx
1st Dec 20219:49 amRNSTotal Voting Rights
1st Nov 202110:08 amRNSLong Term Incentive Plan Option Grant
1st Nov 202110:02 amRNSTotal Voting Rights
19th Oct 20217:00 amRNSBoehringer Ingelheim Exercises Option
1st Oct 20219:51 amRNSTotal Voting Rights
29th Sep 20215:54 pmRNSHolding(s) in Company
29th Sep 20215:36 pmRNSDirectors Dealings / Market Share Purchases
28th Sep 20214:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.